← Back to headlines
BioNTech Shares Rally on Moderna’s Oncology Breakthrough
BioNTech stock climbed as investors reacted positively to Moderna’s successful oncology developments, raising questions about whether competitor success validates BioNTech’s own cancer pipeline.
27 Aug, 21:52 — 27 Aug, 21:52
Sources
Showing 1 of 1 sources
